News
back📌 It is essential to ensure that patients have access to medicines in a sustainable way, recognizing that both those taking tablets 💊 at home and those receiving injections 💉 in hospitals are equally important. We must ensure that all medicines reach patients exactly when they need them ⏳, said Michał Byliniak, General Director of the Association of Employers of Innovative Pharmaceutical Companies (INFARMA)
💬 Panel Discussion: “Pharmaceutical Security in the European Union – Will EU Citizens Have Guaranteed Access to Medicines and Medical Devices?” addressed the issue of access to medicines and medical devices across the EU 🇪🇺. The discussion emphasized the importance of the list of critical medicines 📜 and the revision of pharmaceutical legislation (Pharma Package).
🔹 The need for European cooperation 🤝 in optimizing distribution chains, as well as increasing flexibility and production capacity 🏭, was highlighted to guarantee equal access to medicines. Sustainable development 🌱 and safe production of medical devices must be seen as an investment in public health 🏥. Legal changes 📜 supporting innovation and the use of EU funds 💶 can significantly contribute to achieving these goals.
🔴 The pharmaceutical security panel was one of the five key topics discussed at the “Health and Security for the Future” 📅 conference, summarizing the ROAD TO PRESIDENCY initiative. The event took place at the Medical University of Warsaw 🏛️.
📺 You can still watch the full event on our YouTube channel ▶️ and explore the presented White Paper 📖:
🔸 Conference – https://www.youtube.com/watch?v=zyodp7z1WhE
🔸 White Paper – https://irss.org.pl/wp-content/uploads/White_Paper_IRSS_2025.pdf#PublicHealth
🔷 Panelists included:
🔹 Lech Pilawski, Member of the European Economic and Social Committee, Advisor to the President at the Lewiatan Confederation
🔹 Dr. Grzegorz Cessak, President of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
🔹 Michał Byliniak, General Director of the Association of Employers of Innovative Pharmaceutical Companies (INFARMA)
🔹 Justin Gandy, Managing Director, MSD Poland
🔹 Arkadiusz Grądkowski, President of the National Chamber of Medical Devices POLMED
🔹 Krzysztof Kopeć, President of the Polish Association of Pharmaceutical Industry Employers
🔹 Sibilia Quilici, Executive Director of Vaccines Europe, European Federation of Pharmaceutical Industries and Associations
🔹 Irena Rej, President of the Board of the Polish Chamber of Pharmacy
🔹 Danko Relić, Member of the European Economic and Social Committee
🔹 Jakub Szulc, Deputy President of the National Health Fund (TBC)
#EU2025Presidency #PublicHealth #EuropeanUnion #Healthcare #PharmaceuticalSecurity #WhitePaper #IRSS #Conference #RoadToPresidency #HealthAndSecurityForTheFuture